1. Home
  2. SCNX vs PYPD Comparison

SCNX vs PYPD Comparison

Compare SCNX & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCNX
  • PYPD
  • Stock Information
  • Founded
  • SCNX 2010
  • PYPD 2008
  • Country
  • SCNX United States
  • PYPD Israel
  • Employees
  • SCNX N/A
  • PYPD N/A
  • Industry
  • SCNX Other Pharmaceuticals
  • PYPD Medical/Dental Instruments
  • Sector
  • SCNX Health Care
  • PYPD Health Care
  • Exchange
  • SCNX Nasdaq
  • PYPD Nasdaq
  • Market Cap
  • SCNX 33.6M
  • PYPD 29.1M
  • IPO Year
  • SCNX 2020
  • PYPD 2020
  • Fundamental
  • Price
  • SCNX $3.45
  • PYPD $2.99
  • Analyst Decision
  • SCNX
  • PYPD Strong Buy
  • Analyst Count
  • SCNX 0
  • PYPD 2
  • Target Price
  • SCNX N/A
  • PYPD $10.50
  • AVG Volume (30 Days)
  • SCNX 10.8K
  • PYPD 26.8K
  • Earning Date
  • SCNX 02-18-2025
  • PYPD 02-12-2025
  • Dividend Yield
  • SCNX N/A
  • PYPD N/A
  • EPS Growth
  • SCNX N/A
  • PYPD N/A
  • EPS
  • SCNX 3.55
  • PYPD N/A
  • Revenue
  • SCNX N/A
  • PYPD N/A
  • Revenue This Year
  • SCNX $1,085.75
  • PYPD N/A
  • Revenue Next Year
  • SCNX N/A
  • PYPD N/A
  • P/E Ratio
  • SCNX $1.50
  • PYPD N/A
  • Revenue Growth
  • SCNX 166.67
  • PYPD N/A
  • 52 Week Low
  • SCNX $3.07
  • PYPD $2.37
  • 52 Week High
  • SCNX $44.56
  • PYPD $7.00
  • Technical
  • Relative Strength Index (RSI)
  • SCNX N/A
  • PYPD 44.51
  • Support Level
  • SCNX N/A
  • PYPD $2.88
  • Resistance Level
  • SCNX N/A
  • PYPD $3.48
  • Average True Range (ATR)
  • SCNX 0.00
  • PYPD 0.28
  • MACD
  • SCNX 0.00
  • PYPD -0.02
  • Stochastic Oscillator
  • SCNX 0.00
  • PYPD 19.58

About SCNX Scienture Holdings Inc. Common Stock

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: